BridgeMD
New treatment option for Hemorrhage, Surgical
Official title TranExamic Atomized for Pediatric Post-Operative Tonsillectomy Hemorrhage: Pilot Study
ClinicalTrials.gov ID: NCT06580509
What this study is testing
What is Tranexamic Acid Injectable Product?
Tranexamic Acid Injectable Product is an investigational medicine, given as an inhaled treatment, being studied as a potential treatment for hemorrhage, surgical.
Also referred to as TXA 100mg/ml.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- After a child has their tonsils removed, sometimes they might bleed which can be a problem. There is a special mist medicine called nebulized tranexamic acid (TXA) that might help stop the bleeding without having to touch the sore spot.
- Phase 1: an early, usually small safety study
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 2 to 17
You may be able to join if
- Received a tonsillectomy
- Presents to the ED with secondary\ post-tonsillectomy hemorrhage
- Children between age of 2 to 17 years of age (i.e., before their 18th birthday) \ Secondary post-tonsillectomy hemorrhage is defined as greater than...
You likely can't join if
- Known and documented bleeding or clotting disorder.
- Known pregnancy.
- Patients with known hypersensitivity or allergic response to tranexamic acid.
- Parents or guardians who cannot communicate in English or Spanish.
- Intubation prior to enrollment.
- Previously enrolled patients.
The study team makes the final eligibility decision.
Where it's taking place
- San Antonio, Texas, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 2 years to 17 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include San Antonio, Texas, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.